A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2002
11/07/2002	US20020164603 DNAs and proteins or peptides specific to bacteria of the species Neisseria meningitidis, processes for obtaining them and their biological uses
11/07/2002	US20020164600 PD-L2 molecules: novel PD-1 ligands and uses therefor
11/07/2002	US20020164384 Aquatic animal treatment method and composition containing pimenta extract
11/07/2002	US20020164378 Use of bioactive fraction from cow urine distillate ('Go-mutra') as a bio-enhancer of anti-infective, anti-cancer agents and nutrients
11/07/2002	US20020164360 Topical applying peptide to skin
11/07/2002	US20020164359 Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
11/07/2002	US20020164355 Test to detect antibodies; calibration
11/07/2002	US20020164353 Replication-defective adenovirus human type 5 recombinant as a vaccine carrier
11/07/2002	US20020164348 Inhibitors of viral infection
11/07/2002	US20020164346 Induce, moderate immunology response
11/07/2002	US20020164337 Monoclonal antibodies to the map protein and method of use in treating or preventing infections
11/07/2002	US20020164331 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations
11/07/2002	US20020164326 Genetic engineering; administering immunoglobulins
11/07/2002	US20020164312 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/07/2002	US20020164299 Moderator of gene expression
11/07/2002	DE10121102A1 Triazolopyrimidine Triazolopyrimidines
11/07/2002	CA2665516A1 Drug efflux pump inhibitor
11/07/2002	CA2594883A1 Pharmaceutically active uridine esters
11/07/2002	CA2446514A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002	CA2446064A1 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
11/07/2002	CA2446052A1 Compositions and methods for treating vulvovaginitis and vaginosis
11/07/2002	CA2445995A1 Antibacterial agent
11/07/2002	CA2445978A1 Antigens of group b streptococcus and corresponding dna fragments
11/07/2002	CA2445967A1 Compositions comprising lopinavir and methods for enhancing the bioavailability of pharmaceutical agents
11/07/2002	CA2445861A1 Pharmaceutically active uridine esters
11/07/2002	CA2445826A1 Treatment and diagnosis of macrophage mediated disease
11/07/2002	CA2445819A1 Recombinant expression of hhbv reverse transcriptase (rt)
11/07/2002	CA2445702A1 Control of compactability through crystallization
11/07/2002	CA2445697A1 Drug efflux pump inhibitor
11/07/2002	CA2445593A1 Genetically modified yt cell line and use thereof
11/07/2002	CA2445568A1 Triazole-derived kinase inhibitors and uses thereof
11/07/2002	CA2445565A1 Compositions and methods of double-targeting virus infections and cancer cells
11/07/2002	CA2445382A1 Method for generating highly active human dendritic cells from monocytes
11/07/2002	CA2445376A1 Substance rkb-3564 having angiogenesis inhibitory action
11/07/2002	CA2445373A1 Use of phyllanthus constituents for treating or preventing infections caused by hepatitis b viruses
11/07/2002	CA2445357A1 Pyrazole derived kinase inhibitors
11/07/2002	CA2445338A1 G-protein coupled receptors
11/07/2002	CA2445310A1 Multivalent vaccine comprising an hiv antigen and an hsv antigen and/or an hpv antigen
11/07/2002	CA2445294A1 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
11/07/2002	CA2445290A1 A pharmaceutical tablet having a high api content
11/07/2002	CA2445266A1 Foot and mouth disease virus vaccine
11/07/2002	CA2444897A1 Sulfate of cephem compound
11/07/2002	CA2440775A1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use
11/07/2002	CA2438223A1 Carboxylic acid such as citric acid for desinfecting or enhacing the production of blood products such as plasma, cryoprecipitate or/and platelet
11/06/2002	EP1255112A2 Treatment of T-cell mediated diseases
11/06/2002	EP1254944A1 Dry compositions containing hydrophobic amino acid
11/06/2002	EP1254906A1 Tetrahydrothiopyran phenyloxazolidinone S,S-dioxides
11/06/2002	EP1254898A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
11/06/2002	EP1254663A1 Anti-virus agent
11/06/2002	EP1254659A1 Stable emulsion compositions
11/06/2002	EP1254657A2 Liposomes
11/06/2002	EP1254270A1 Methods and materials relating to cub domain polypeptides and polynucleotides
11/06/2002	EP1254268A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
11/06/2002	EP1254253A1 Single stranded oligonucleotides, probes, primers and method for detecting spirochetes
11/06/2002	EP1254240A2 Proteins producing an altered immunogenic response and methods of making and using the same
11/06/2002	EP1254239A2 Mammalian secreted group iii phospholipase a2
11/06/2002	EP1254235A2 Drug metabolizing enzymes
11/06/2002	EP1254234A1 Haemophilus influenza outer membrane protein and use thereof in vaccination
11/06/2002	EP1254233A1 Use of a leptospire protein for preventing and/or diagnosing and/or treating animal and/or human leptospirosis
11/06/2002	EP1254224A2 Interferon-alpha induced genes
11/06/2002	EP1254214A2 Human protein kinases and protein kinase-like enzymes
11/06/2002	EP1254213A2 Recombinant attenuation of prrsv
11/06/2002	EP1254212A2 Methods of preparing and using a viral vector library
11/06/2002	EP1254164A2 Selective n-acylation of a82846 glycopeptide analogs
11/06/2002	EP1254161A2 Aerothricin analogs, their preparation and use
11/06/2002	EP1254146A1 Processes for preparing clarithromycin polymorphs and novel polymorph iv
11/06/2002	EP1254133A2 Indol-3-yl derivatives
11/06/2002	EP1254131A1 Extraction of flavonoids
11/06/2002	EP1254130A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
11/06/2002	EP1254123A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
11/06/2002	EP1254119A1 Pyrimidine derivatives as selective inhibitors of cox-2
11/06/2002	EP1254114A2 Melanocortin receptor agonists and antagonists
11/06/2002	EP1254111A1 Novel vitamin d analogues
11/06/2002	EP1253939A1 In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent
11/06/2002	EP1253924A1 Nitrate salts of antimicrobial agents
11/06/2002	EP1157024B1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
11/06/2002	EP1112076A4 Polymeric compounds and methods of formulating same
11/06/2002	EP1109818B1 Phosphoepoxides, method for making same and uses
11/06/2002	EP1097159B1 Phosphinous and phosphonic acid derivatives used as medicaments
11/06/2002	EP1031570B1 Immuno-modulator exhibiting anti-microbial and anti-mycobacterial activities, method for producing the same and pharmaceutical preparation for treating mycobacterioses as well as lung chronic and non specific conditions, sexually transmitted diseases and the resulting immuno-deficiency
11/06/2002	EP1001789B1 Product comprising at least a double stranded rna combined with at least a 6-benzyluracil derivative for a simulatneaous, separated or time-spreaded therapeutic use
11/06/2002	EP0971923B1 Synthesis of acyclic nucleoside derivatives
11/06/2002	EP0966487B1 Polyvalent carbohydrate molecules
11/06/2002	EP0920421B1 Isoxazoline derivatives useful as antimicrobials
11/06/2002	EP0919562B1 Phosphonate nucleotide compounds
11/06/2002	EP0901488B1 2,4-diaminopyrimidine derivatives
11/06/2002	EP0871619B1 Phenyl thiazole derivatives with anti herpes virus properties
11/06/2002	EP0741577B1 The use of interferon subtype alpha 8 in the preparation of medicaments to treat viral infections of the liver
11/06/2002	EP0726758B1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
11/06/2002	EP0689550B1 Antimicrobial peptides from bovine neutrophils
11/06/2002	CN1378597A Immunogenic polypeptides derived from morazella catarrhalis and uses thereof
11/06/2002	CN1378596A BASB 111 polypeptide and polynucleotide from moraxella cathraahalis
11/06/2002	CN1378560A Compounds for treatment of infectious and immune system disorders and method for their use
11/06/2002	CN1378554A Novel fusidic acid derivatives
11/06/2002	CN1378553A Expression of immunogenic hepatitis B surface antigens in transgenic plants
11/06/2002	CN1378551A 嘌呤衍生物 Purine derivatives
11/06/2002	CN1378546A Antibiotic sultam and sultone drived oxazolidiones
11/06/2002	CN1378544A Substituted azoles compounds
11/06/2002	CN1378542A FAB I inhibitors
11/06/2002	CN1378541A Inhibitors of c-JUN N-terminal kinase (JNK) and other protein kinases

1 ... 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 ... 1798